TS
EW icon

Triglav Skladi’s Edwards Lifesciences EW Stock Holding History

Triglav Skladi’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63M Hold
18,060
– – 0.09% 116
2026
Q1 		$1.45M Hold
18,060
– – 0.1% 107
2025
Q4 		$1.54M Sell
18,060
-2,000
-10% -$164K 0.1% 106
2025
Q3 		$1.56M Hold
20,060
– – 0.1% 91
2025
Q2 		$1.57M Hold
20,060
– – 0.11% 90
2025
Q1 		$1.45M Hold
20,060
– – 0.12% 88
2024
Q4 		$1.49M Buy
+20,060
New +$1.4M 0.12% 88

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Triglav Skladi's EW Position: Q2 2026 in Review

Triglav Skladi held its Edwards Lifesciences (EW) position steady in Q2 2026 at 18,060 shares worth $1.63M. The position accounts for 0.09% of the portfolio, ranked #116.

Triglav Skladi first reported a position in EW in Q4 2024 and has held it in 7 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Triglav Skladi held 18,060 shares of Edwards Lifesciences worth $1.63M as of Q2 2026.
  • Triglav Skladi left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.09% of Triglav Skladi's portfolio in Q2 2026, its #116 holding.
  • Triglav Skladi first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 7 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Triglav Skladi's 13F filing for Q2 2026, filed 11 Aug 2026.